Supplementation with acetate during influenza infection supported lung defenses against secondary pneumococcal infection in a free fatty acid receptor 2 (FFAR2)-dependent manner, thereby augmenting the lethal outcomes. The gene discussed is FFAR2; the disease is pneumococcal infection.